MDS prognosis: Outlook and life expectancy - Medical News Today
Myelodysplastic syndrome (MDS) is a type of cancer in which the bone marrow does not produce healthy cells. Find out here about the outlook and life expectancy for a person with MDS.
What are the Differences Between MDS and AML? - HealthTree
Treatment differences between MDS and AML MDS treatment depends highly on the risk status. Treatment may include supportive care measures, such as blood transfusions or medications to …
Distinguishing AML from MDS: a fixed blast percentage may …
Patients with acute myeloid leukemia (AML) have conventionally received more intense therapy than patients with myelodysplastic syndrome (MDS). Although less intense therapies are being used …
Myelodysplastic Syndrome (MDS): Symptoms, Diagnosis
Myelodysplastic syndrome (also called myelodysplasia or MDS) affects blood stem cells. People with MDS don’t have enough healthy blood cells. MDS can cause anemia, frequent infections and …
About Myeloid Malignancies | Center for Cancer Research
The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) are a heterogeneous group of malignant clonal hematopoietic stem cell disorders. MDS is characterized by ineffective …